EUVIMEDEUVIMED entdecken
Crossref

Synergistic impact of insulin resistance and hepatic fibrosis on cardiovascular events in patients with coronary artery disease: A machine learning subtyping and interaction analysis

Zhihao Zheng, Wanqing Sun, Han Xu, Yanjun Song, Jining He, Xiaohui Bian, Bowen Li, Chenxi Song, Rui Fu, Kefei Dou

Nutrition, Metabolism and Cardiovascular Diseases · 2025

DOI: 10.1016/j.numecd.2025.104520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Zhihao Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Me…. Hauptthemen laut MEDLINE: Insulin Resistance, Liver Cirrhosis, Coronary Artery Disease, Unsupervised Machine Learning. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Fuwai Hospital, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Insulin resistance (IR) and hepatic fibrosis are significant yet underexplored synergistic risk factors for cardiovascular events in coronary artery disease (CAD). We investigated the interaction between the triglyceride-glucose (TyG) index and liver fibrosis scores (FIB-4, BARD) for risk prediction. METHODS AND RESULTS: Within a prospective cohort of 14,660 CAD patients, we performed a data-driven phenotypic stratification using K-means clustering-an unsupervised machine learning algorithm-to deconvolute heterogeneous metabolic profiles. Subsequently, Cox regression models were employed to evaluate associations of these phenotypes, along with continuous and tertiled TyG, FIB-4, and BARD scores, with incident cardiovascular events (a composite of cardiovascular mortality, nonfatal myocardial infarction, or stroke). The analysis identified three mechanistically distinct metabolic subtypes. During a median follow-up of 3 years, 463 cardiovascular events occurred (overall event rate: 3.16 %). The "metabolic-fibrosis mixed" subtype exhibited the highest risk (adjusted HR = 1.71, 95 %CI:1.34-2.19), with an event rate of 4.40 % (183/4159) compared to 2.43 % (116/4782) in the low-risk subtype. Both the TyG index (HR = 1.52, 95 %CI:1.40-1.65) and BARD score were independent predictors. A significant multiplicative interaction existed between TyG and BARD (P = 0.041). Additive interaction analysis confirmed synergy, with a relative excess risk (RERI) of 1.42 when both biomarkers were elevated. Risk escalated nonlinearly once TyG exceeded 9.0, potentiated by fibrosis. CONCLUSION: IR and hepatic fibrosis synergistically increase cardiovascular risk in CAD patients. Combining TyG and BARD scores with metabolic subtyping enhances risk stratification, potentially guiding targeted interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceLiver CirrhosisCoronary Artery DiseaseUnsupervised Machine LearningHumansMaleRisk AssessmentMiddle AgedFemaleBiomarkersProspective StudiesPrognosisAgedTime FactorsPredictive Value of TestsRisk FactorsPredictive Learning ModelsBlood GlucoseTriglyceridesClustering AlgorithmsIncidencePhenotype

Stichwörter der Autor:innen

Cardiovascular eventsHepatic fibrosisInsulin resistanceInteraction analysisMachine learning

Substanzen

BiomarkersBlood GlucoseTriglycerides

Autor:innen und Institutionen

  • Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; State Key Laboratory of Cardiovascular…

Förderung

  • Fundamental Research Funds for the Central Universities
  • Fuwai Hospital
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Zitieren

APA

Zheng, Z., Sun, W., Xu, H., Song, Y., He, J., Bian, X., Li, B., Song, C., Fu, R., & Dou, K. (2025). Synergistic impact of insulin resistance and hepatic fibrosis on cardiovascular events in patients with coronary artery disease: A machine learning subtyping and interaction analysis. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2025.104520

Vancouver

Zheng Z, Sun W, Xu H, Song Y, He J, Bian X, et al. Synergistic impact of insulin resistance and hepatic fibrosis on cardiovascular events in patients with coronary artery disease: A machine learning subtyping and interaction analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2025.104520

BibTeX
@article{Zheng2025,
  author = {Zheng, Zhihao and Sun, Wanqing and Xu, Han and Song, Yanjun and He, Jining and Bian, Xiaohui and Li, Bowen and Song, Chenxi and Fu, Rui and Dou, Kefei},
  title = {Synergistic impact of insulin resistance and hepatic fibrosis on cardiovascular events in patients with coronary artery disease: A machine learning subtyping and interaction analysis},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2025},
  doi = {10.1016/j.numecd.2025.104520}
}
Kostenlos starten →